Molecular diagnostics: market dynamics and future developments

7 June 2012 - By Departement IT

Our consultancy firm’s publication | CEPTON Strategies

Colloque France Biotech, le 7 juin 2012. Molecular diagnostics is the key to personalized medicine. In that respect, it has a promising future. However, the regulatory and market access landscapes are still fragmented and lack a clear framework. Many barriers still remain today. CEPTON has spoken at France Biotech’s congress on this topic in Paris, on June 7, 2012.

Request the full study by using our contact formular.

CEPTON Strategies news

Here are all the reports and analysis we published along with the press articles about us

CEPTON is the author of many publications in the field of healthcare and pharmaceuticals and our partners are often interviewed by the specialized press.

Connected Medical Devices: Thriving opportunities for better healthcare (Part II)

Posted on 23.03.2021 by Marc-Olivier Bévierre

See more

Posted on 23.03.2021 by Marc-Olivier Bévierre

See more

Connected Medical Devices: Thriving opportunities for better healthcare (Part I)

Posted on 25.02.2021 by Marc-Olivier Bévierre

See more

Connected medical devices embedded in AI: the wave is coming

Posted on 14.01.2021 by Marc-Olivier Bévierre

See more

Objets connectés

Posted on 14.01.2021 by Marc-Olivier Bévierre

See more

CEPTON strengthens its management team in Paris and appoints 3 new Associate Partners

Posted on 28.10.2020 by Marc-Olivier Bévierre

See more

Contact us

You have a question, an issue you would like to share with us

Feel free to contact us to arrange a meeting or a teleconference, using the form below.

You would like to apply for a job with us

We are always happy to welcome new profiles in our teams, please fill the following form to apply for a job in CEPTON.